Background
==========

The original article by Rivers et al[@b1-oaem-8-001] published in 2001 showed the huge benefit of a lower mortality rate in severe sepsis and septic shock patients from 46.5% to 30.5%. Early goal-directed therapy (EGDT) is a sepsis cardiovascular support protocol aimed at early hemodynamic optimization, which became standard treatment for severe sepsis and septic shock patients according to the Surviving Sepsis Campaign guidelines for the management of severe sepsis and septic shock in 2004.[@b2-oaem-8-001] The original research was conducted in a critical care unit; however, the principles are to bring blood circulation back to normal as soon as possible. In practice, septic shock patients present commonly in the emergency room. Therefore, the implementation of EGDT in the emergency room is essential. Recent studies show that the implementation of EGDT in the emergency room can be achieved and that it has benefits.[@b3-oaem-8-001],[@b4-oaem-8-001]

Songklanagarind Hospital is a tertiary care and referral center in southern Thailand. There are more than 42,000 cases each year. in the emergency room. EGDT was implemented in the emergency room of Songklanagarind Hospital in 2010. This study was conducted to determine the success rate of applying EGDT in the emergency room.

The primary outcome is to achieve the EGDT goals, which are defined as central venous pressure (CVP) ≥8 mmHg, mean arterial pressure (MAP) ≥65 mmHg, and central venous oxygen saturation (ScvO~2~) ≥70%. The secondary outcome is to determine to what extent the survival rates can improve.

Methods
=======

This was a prospective observational study held in the emergency department between April 1 and September 30, 2013. The study was approved by the research quality and safety control committee of Prince of Songkla University. Only newly diagnosed septic shock patients who were of age ≥18 years, received EGDT, and submitted signed written consent forms were enrolled. The recorded data included the chief compliant, initial vital signs, past medical history, laboratory tests, initial and final diagnoses, severity scores (Sequential Organ Failure Assessment \[SOFA\], Simplified Acute Physiology II \[SAP II\], and Acute Physiology and Chronic Health Evaluation \[APACHE II\]), time to reach the goals (CVP ≥8 mmHg, MAP ≥65 mmHg, and ScvO~2~ ≥70%), and the results of treatment (death or improved). Only the cases of those patients or authorized representatives who signed a written consent form and had complete medical research charts were enrolled into the study. All others were excluded.

As soon as the patient was diagnosed as having septic shock, the severe sepsis and septic shock campaign guideline of 2008 ([Figure 1](#f1-oaem-8-001){ref-type="fig"})[@b5-oaem-8-001] was followed and parameters were recorded. Volume resuscitation, central venous catheter insertion (subclavian vein or internal jugular vein), and isotonic crystalloid were used to achieve a CVP of 8--12 mmHg. Vasopressors were added if necessary to reach the target MAP of 65 mmHg. Packed red blood cells and/or dobutamine were given when needed to reach the target ScvO~2~ of ≥70%. The times to reach the goals were also recorded.

After the time to reach the goals was recorded, the patients were divided into two groups: achieved goal group and nonachieved goal group. The achieved goal group included those patients who had attained an ScvO~2~ ≥70% within 6 hours, and any patient who could not achieve the aforementioned ScvO~2~ level within 6 hours was allocated to the nonachieved goal group. The emergency physician who took care of the septic shock patients had to record the actual time the EGDT goal was achieved, while the results of the treatment (death or improved) were recorded by a research assistant. The primary end point of this study was the achieved EGDT goal rate, represented as a percentage, and the secondary end point was the mortality rates of the two groups: achieved and nonachieved goal groups. For the statistical analysis, the *t*-test and Mann--Whitney *U*-test were applied.

Results
=======

There were 101 initially diagnosed severe sepsis and septic shock patients between April 1 and September 30, 2013, according to the definition of the severe sepsis and septic shock campaign 2008,[@b5-oaem-8-001] who were aged ≥18 years and registered in the EGDT registry, but only 55 patients were enrolled in this study. Of the 46 patients not enrolled in this study, 24 refused central venous catheter insertion, 17 were referred to other hospitals, four were finally diagnosed as other causes of shock, and one was aged under 18 years. Twenty-eight (50.9%) of the 55 enrolled patients were male, and the mean age was 65.1 years. In 17 cases (30.9%), the cause of infection could not be identified. Among 38 patients, 20 (36.4%) were diagnosed as having pneumonia, nine (16.36%) as having infective gastroenteritis and hepatobiliary tract infection, eight (14.5%) as having urinary tract infection, six as having (10.9%) skin and soft tissue infection, two as having spontaneous bacterial infection, and one as having osteomyelitis. Hemoculture results were reported as positive in 33 (60%) cases. Twenty-two (40%) patients had acute renal failure, 23 (41.8%) needed mechanical ventilator, and 52 (94.5%) needed vasoactive agent. The mean serum lactate in the achieved goal group was 3.6 mmol/L, and the mean serum lactate in the nonachieved goal group was 5.3 mmol/L (*P*=0.498). The demographic data are listed in [Tables 1](#t1-oaem-8-001){ref-type="table"} and [2](#t2-oaem-8-001){ref-type="table"}.

Primary analysis
----------------

There were 39 patients who achieved the EGDT goals and 16 who did not achieve the EGDT goals within 6 hours. The mean SAP II, APACHE II, and SOFA scores in the achieved and nonachieved EGDT goal groups ([Table 3](#t3-oaem-8-001){ref-type="table"}) were not statistically significantly different between the two groups. The mean times to receive antibiotics in the achieved goal group and nonachieved goal group were 64 and 58 minutes, respectively, with no statistical significance between the two groups (*P*=0.405).

[Table 4](#t4-oaem-8-001){ref-type="table"} lists the resuscitative procedures and agents that were used in the two groups. In the achieved and nonachieved goal groups, vasoactive agents were used in 97.4% and 87.5% of the cases, respectively, and mechanical ventilation was applied in 41.0% and 43.8% of the cases, respectively, which showed no statistical significance. However, blood transfusion between the achieved and nonachieved goal groups was significant (12.8% vs 37.5%, respectively) (*P*\<0.01).

Sixteen patients in the nonachieved EGDT goal group achieved CVP ≥8 mmHg within 6 hours. Only one of them did not achieve MAP ≥65 mmHg, and nine of them did not achieve urine output ≥0.5 mL/h, and 15 of them did not achieve ScvO~2~ ≥70% ([Table 5](#t5-oaem-8-001){ref-type="table"}).

Secondary outcome
-----------------

Of the 39 patients, nine who achieved goal within 6 hours or a survival rate of 76.9% died. Of the 16 patients who did not achieve goal within 6 hours, 15 who showed a survival rate of 6.3% died. There was a statistically significant difference of increased mortality rate between the two groups (*P*\<0.01) ([Table 6](#t6-oaem-8-001){ref-type="table"}). The need of vasoactive agents and mechanical ventilation was not statistically significant between the two groups. In the nonachieved goal group, 37.5% of the patients needed blood transfusion compared with 12.8% in the achieved goal group (*P*\<0.01).

Discussion
==========

Early hemodynamic optimization is crucial and has an effect on the mortality rate in severe sepsis and septic shock patients. Since EGDT became the standardized treatment for severe sepsis and septic shock in 2001, there are many reports on the implementation of EGDT in the emergency room. Previous research showed that implementation of the EGDT guideline in the emergency room can be successfully done even in a community-based hospital.[@b6-oaem-8-001] The success rates of applying and achieving the EGDT goals were 78%--91%, and the mortality rates decreased by 20%--60%.[@b4-oaem-8-001]--[@b6-oaem-8-001]

Therefore, EGDT was implemented in the emergency room of Songklanagarind Hospital in 2010. Patients who presented with fever, aged ≥18 years, and an initial diagnosis of severe sepsis and septic shock according to the Sepsis Campaign Guideline 2008 were treated according to the EGDT guideline by the emergency physicians.

The primary outcome of this study was the success rate of achieving EGDT goal within 6 hours, defined by CVP ≥8--12 mmHg, MAP ≥65 mmHg, urine output ≥0.5 mL/kg/h, and ScvO~2~ ≥70% according to the original article by Rivers et al.[@b1-oaem-8-001] The original article reported the median time of the CVP goal as 6 hours, MAP goal as 4 hours, and ScvO~2~ goal as 5 hours. In this study, among the 16 patients in the nonachieved goal group, all achieved CVP ≥8--12 mmHg and 93.8% of them achieved MAP ≥65 mmHg, but none of them achieved ScvO~2~ ≥70%, which was statistically significant (*P*\<0.001). ScvO~2~ indicates whether oxygen delivery is adequate to meet a patient's needs. [Tables 1](#t1-oaem-8-001){ref-type="table"} and [2](#t2-oaem-8-001){ref-type="table"} list the hematocrits of the patients in the two groups. The mean hematocrits of patients in the achieved goal group and the nonachieved goal group were 31.7 and 22.4, respectively, which was statistically significant (*P*\<0.001). However, there are many reasons for a decrease in the ScvO~2~: 1) it indicates that tissues are extracting a higher percentage of oxygen from the blood than normal, 2) the individual's cardiac output is not high enough to meet their needs, and 3) the hemoglobin may be too low.

The secondary outcome in this study was to determine how much EGDT improved the mortality rate in severe sepsis and septic shock. The mortality rate in severe sepsis and septic shock can be affected by many factors, such as previous medical illness, cause of sepsis, quality of resuscitation and time antibiotics were given, and severity of the illness. To decrease the bias of the study, the time to initiate antibiotics, initial diagnosis, and severity of illness were recorded ([Tables 1](#t1-oaem-8-001){ref-type="table"} and [2](#t2-oaem-8-001){ref-type="table"}). [Tables 1](#t1-oaem-8-001){ref-type="table"} and [2](#t2-oaem-8-001){ref-type="table"} list the demographic data that may affect the results of treatment, such as age, sex, immune status, causes of sepsis, initial serum lactate, time to initiate antibiotics, initial hematocrit, and level of consciousness, all of which showed no statistical significance between the two groups. [Table 3](#t3-oaem-8-001){ref-type="table"} lists the results of the severity scores, which showed no statistical significance between the two groups. [Table 4](#t4-oaem-8-001){ref-type="table"} lists the resuscitative procedures and agents that were used, such as vasoactive agents, mechanical ventilation, and blood transfusion. The need of vasoactive agents and mechanical ventilation was not statistically significant between the two groups. However, the need for blood transfusion was quite significant in the nonachieved goal group. This may be because the initial hematocrits were lower in this group ([Tables 1](#t1-oaem-8-001){ref-type="table"} and [2](#t2-oaem-8-001){ref-type="table"}). The data showed a 23.1% mortality rate in the achieved goal group compared with 93.8% in the nonachieved goal group (ScvO~2~ \<70%). The benefits of applying EGDT were also observed in other studies.[@b7-oaem-8-001],[@b8-oaem-8-001] Puskarich et al[@b7-oaem-8-001] showed the benefits of EGDT by a decrease in mortality rate from 49% before implementation of the guideline to 37% after implementation of the guideline. Huang et al[@b9-oaem-8-001] showed that the benefits of EGDT were not only a decrease in the mortality rate, but also a decrease in the length of hospital stay and cost. In 2010, a multicenter randomized trial of 300 sepsis patients reported no differences in the in-hospital mortality rate between septic shock patients who were treated to normalized lactate clearance compared with ScvO~2~.[@b10-oaem-8-001]

The ARISE trial,[@b11-oaem-8-001] and ProCESS trial,[@b12-oaem-8-001] were two recent multicenter trials to determine whether the EGDT protocol could improve the mortality rate compared with usual care group. They concluded that there were no statistically significant differences between the mortality rates and lengths of hospital stay between those two groups. However, the ARISE trial and ProCESS trial defined the usual care group as treated by bedside provider-directed care without protocols. They showed, no actual methods or parameters for resuscitation and no care guidelines. Moreover, the final outcomes showed no statistical significance between the amount of fluid, and ScvO~2~ at 6 hours after resuscitation.

Conclusion
==========

The key for the treatment of severe sepsis and septic shock is to optimize the patient's hemodynamic functions. EGDT is a useful tool to guide resuscitation in the emergency room. The success rate of applying EGDT in the emergency room in this study was 70.9%. The data showed that for septic shock patients who achieved the EGDT goals within 6 hours, the mortality rate decreased from 93.8% to 23.1% compared with patients who could not achieve the EGDT goals within 6 hours.
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![Early goal-directed-therapy guideline.\
**Notes:** This protocol should be initiated within 1 hour of presentation (or severe sepsis identification) and continued for at least the first 6 hours of resuscitation. ^a^If PA catheter is inserted, PCWP target of 12--15 mmHg replaces CVP target, and ScvO~2~ ≥70% replaces ScvO~2~ target.\
**Abbreviations:** SBP, systolic blood pressure; MAP, mean arterial pressure; IVF, intravenous fluid; PA, pulmonary artery; PCWP, pulmonary capillary wedge pressure; CVP, central venous pressure; ScvO~2~, central venous oxygen saturation.](oaem-8-001Fig1){#f1-oaem-8-001}

###### 

Demographic data

  Factor                                                             Achieved goal group (n=39)   Nonachieved goal group (n=16)   Total (N=55)   *P*-value
  ------------------------------------------------------------------ ---------------------------- ------------------------------- -------------- -----------
  Sex                                                                                                                                            
   Male                                                              18 (46.2%)                   10 (62.5%)                      28 (50.9%)     0.271
   Female                                                            21 (53.8%)                   6 (37.5%)                       27 (49.1%)     
  Immunocompromised host[a](#tfn1-oaem-8-001){ref-type="table-fn"}   23 (59.0%)                   13 (81.3%)                      36 (65.5%)     0.115
  Hemoculture                                                                                                                                    
   Positive                                                          13 (33.3%)                   9 (56.3%)                       22 (40.0%)     0.115
   Negative                                                          26 (66.7%)                   7 (43.8%)                       33 (60.0%)     
  Final diagnosis                                                                                                                                
   Pneumonia                                                         15 (38.5%)                   5 (31.3%)                       20 (36.4%)     0.614
   Hepatobiliary infection                                           2 (5.1%)                     1 (6.3%)                        3 (5.5%)       1.000
   Urinary tract infection                                           5 (12.8%)                    3 (18.8%)                       8 (14.5%)      0.571
   Infective Gastroenteritis                                         6 (15.4%)                    0 (0.0%)                        6 (10.9%)      0.165
   Skin and soft tissue                                              4 (10.3%)                    1 (6.3%)                        5 (9.1%)       1.000
   Septic arthritis                                                  1 (2.6%)                     0 (0.0%)                        1 (1.8%)       1.000
   Osteomyelitis                                                     1 (2.6%)                     0 (0.0%)                        1 (1.8%)       1.000
   Spontaneous bacterial Peritonitis                                 1 (2.6%)                     1 (6.3%)                        2 (3.6%)       1.000
   Septicemia                                                        9 (23.1%)                    8 (50.0%)                       17 (30.9%)     0.062

**Note:**

Immunocompromised host includes those with end-stage renal disease, on immune suppressant drugs, diabetes, leukemia, organ transplant host, neutropenic patient (neutrophils \<500/mL).

###### 

Demographic data

  Continuous variable data                      Achieved goal group (n=39)   Nonachieved goal group (n=16)   *P*-value                         
  --------------------------------------------- ---------------------------- ------------------------------- ------------- ------------------- ---------
  Age (yr)                                      63.6 (15.6)                  62 (52--79)                     67.3 (13.6)   67 (57.8--80)       0.405
  Initial serum lactate                         3.6 (3.7)                    24 (1.2--4.7)                   5.3 (5.2)     3.3 (1--11.1)       0.498
  Glasgow coma scale score                      12.9 (3.8)                   15 (12--15)                     13.4 (3.3)    15 (12.8--15)       0.652
  Hematocrit                                    31.7 (7.4)                   33 (26--36.1)                   22.4 (5.7)    23.5 (20.0--26.7)   \<0.001
  Time to antibiotic started (door to needle)   1:04 (1:03)                  0:55 (0:30--1:10)               0:58 (0:29)   0:50 (0:36--1:22)   0.669

**Abbreviations:** SD, standard deviation; yr, years.

###### 

Comparison of the mean and median SAP II, APACHE II, and SOFA scores between the two groups

  Severity score   Achieved EGDT goal group (n=39)   Nonachieved goal group (n=16)   *P*-value                       
  ---------------- --------------------------------- ------------------------------- ----------- ------------------- --------
  SAP II           31.9±26.9                         21.3 (9.7--55.3)                43.2±28.5   35.0 (17.1--71.2)   0.0097
  APACHE II        46.0±23.0                         46.0 (26.2--63.9)               59.9±23.8   62.2 (40.7--83.5)   0.058
  SOFA             8.8±2.8                           9 (7--11)                       10.1±2.5    10 (8--12)          0.105

**Abbreviations:** SAP II, Simplified Acute Physiology II; APACHE II, Acute Physiology and Chronic Health Evaluation II; SOFA, Sequential Organ Failure Assessment; EGDT, early goal-directed therapy; SD, standard deviation.

###### 

Resuscitative procedures and agents

  Resuscitative procedure/agent          Achieved goal group (n=39)   Nonachieved goal group (n=16)   *P*-value
  -------------------------------------- ---------------------------- ------------------------------- -----------
  Vasoactive agent needed, n (%)         38 (97.4)                    14 (87.5)                       0.200
  Mechanical ventilation needed, n (%)   16 (41.0)                    7 (43.8)                        0.852
  Blood transfusion needed, n (%)        5 (12.8)                     6 (37.5)                        \<0.01

###### 

Target early goal-directed therapy achieved within 6 hours in the achieved goal and nonachieved goal groups

  Goals reached \<6 hours      Achieved goal group, n (%)   Nonachieved goal group, n (%)   Total, n (%)   *P*-value
  ---------------------------- ---------------------------- ------------------------------- -------------- -----------
  CVP ≥8--12 mmHg                                                                                          
   Yes                         39 (100)                     16 (100)                        55 (100)       --
   No                                                                                                      
  MAP ≥65 mmHg                                                                                             
   Yes                         39 (100)                     15 (93.8)                       54 (98.2)      0.291
   No                          0                            1 (6.3)                         1 (1.8)        
  Urine output ≥0.5 m L/kg/h                                                                               
   Yes                         39 (100)                     7 (43.8)                        46 (83.6)      \<0.001
   No                          0                            9 (56.3)                        9 (16.4)       
  ScvO~2~ ≥70%                                                                                             
   Yes                         39 (100)                     0 (0)                           39 (70.9)      \<0.001
   No                          0                            15 (100)                        15 (27.3)      

**Abbreviations:** CVP, central venous pressure; MAP, mean arterial pressure; ScvO~2~, central venous oxygen saturation.

###### 

Survival and mortality rates of the achieved and nonachieved goal groups

  Outcome    Achieved goal (n=39) (%)   Nonachieved goal (n=16) (%)   *P*-value
  ---------- -------------------------- ----------------------------- -----------
  Survived   30 (76.9)                  1 (6.3)                       \<0.001
  Dead       9 (23.1)                   15 (93.8)                     
